Selected Publications
Sivendran S, Lynch S, McNaughton C, Wong R, Svetec S, Moore JH, Holliday R, Oyer RA, Newport K.: Anticancer Therapy at the End of Life: Lessons From a Community Cancer Institute. J Palliat Care. 36 (2): 87-92,2021.
Newport K, Sivendran S.: Including the Oncologist in Palliative Oncology: A Response to Nature of Discussions about Systemic Therapy Discontinuation or Hospice among Patients, Families, and Palliative Care Clinicians during Care for Incurable Cancer: A Qualitative Study. J Palliat Med. 23 (4): 451-452,2020.
McNaughton CH, Horst M, Gehron E, Sivendran S, Nguyen J, Holliday R, Newport K.: Patterns of Support Service, Emergency Department and Hospital Utilization in Patients with Advanced Cancer: A Descriptive Study. J Palliat Care. 35 (1): 34-39,2020.
Finlay E, Newport K, Sivendran S, Kilpatrick L, Owens M, Buss MK: Models of Outpatient Palliative Care Clinics for Patients With Cancer. J Oncol Pract
15 (4): 187-193,2019.
Sivendran S, Jenkins S, Svetec S, Horst M, Newport K, Yost KJ, Yang M.: Illness Understanding of Oncology Patients in a Community-Based Cancer Institute. J Oncol Prac. 13 (9): e800-e808.,2017.
Wyluda E, Newport K, Sauder M, Sivendran S.: Safety and efficacy of vandetanib in the treatment of medullary thyroid cancer. Journal of Signs and Symptoms 3 (2): 2016.
Sivendran S, Galsky MD.: Adverse event reporting in oncology clinical trials - lost in translation? Expert Opin Drug Saf
15 (7): 893-6,2016.
Sivendran S, Holliday R, Guittar R, Cox C, Newport K: The impact of a nurse practitioner-led symptom clinic on emergency department use in cancer patients. Journal of Community and Supportive Oncology 14 (6): 268-272,2016.
Perkins SH, Stensland KD, Galsky MD, Sivendran S.: Reporting quality of abstracts in phase III clinical trials of systemic therapy in metastatic solid malignancies. Trials
16 : 341,2015.
Gartrell BA, Ying J, Sivendran S, Boucher KM, Choueiri TK, Sonpavde G, Oh WK, Agarwal N, Galsky MD.: Pulmonary complications with the use of mTOR inhibitors in targeted cancer therapy: a systematic review and meta-analysis. Target Oncol. 9 (3): 195-204,2014.
Academic Contact Information
Ann B. Barshinger Cancer Institute
2102 Harrisburg Pike
Lancaster ,
PA
17601
Patient appointments: 800-789-7366